City
Epaper

EU concludes exploratory talks to buy potential Covid-19 vaccine

By IANS | Updated: August 21, 2020 15:01 IST

-million-euro loan agreement for the development and large-scale production of vaccines, including CureVac's vaccine candidate against COVID-19. CureVac ...

Open in App

-million-euro loan agreement for the development and large-scale production of vaccines, including CureVac's vaccine candidate against COVID-19.

 

CureVac is the fourth partner the Commission has announced to have been talking with.

So far the Commission has signed an actual advance purchase agreement with AstraZeneca, and published "positive steps" with Sanofi-GSK and Johnson & Johnson.

 

( With inputs from IANS )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: commissionAstrazeneca
Open in App

Related Stories

HealthDCGI Orders Withdrawal of AstraZeneca’s Anti-Cancer Drug Olaparib for Certain Treatments

HealthAfter Covishield, BHU Study Reveals Side Effects of Covaxin; Including Hair Loss, Skin Issues, and Menstrual Irregularities

InternationalAstraZeneca Withdraws COVID-19 Vaccine Globally Days After Side Effect Row, Firm Says Decision ‘Commercial’

NationalCovaxin-Developer Bharat Biotech Amid Reports on AstraZeneca Vaccine, Says ‘Safety Is Primary Focus for All Our Vaccines’

NationalCovishield Vaccine Side Effect: Serum Institute Faces Legal Action As Parents of Deceased Girls Prepare Lawsuit

Health Realted Stories

HealthSC to hear on Monday plea against two shifts in NEET PG 2025

HealthAngolan President seeks closer ties with India in pharma, agriculture, renewable energy

HealthHand hygiene is not a luxury, it is the cornerstone of safe healthcare: Saima Wazed

HealthSouth Korea reports 52 cases of measles, highest in 6 years

HealthScientists find details of process driving evolution, major diseases